Xq. Huang et al., Study on mechanism of interaction of nociceptin and opioids binding with opioid receptor-like 1 receptor, ACT PHAR SI, 21(6), 2000, pp. 536-546
AIM: To study the mechanism of interaction of nociceptin and opioids with O
RL1 receptor. METHODS: Molecular dynamics study was carried out before noci
ceptin was manually docked into the binding site of ORL1 receptor; DOCK4. 0
program was applied to dock four stereoisomers of lofentanyl and etorphine
into the binding pocket of ORL1 receptor. Binding energies were calculated
, the relationship between binding energy and binding affinity was studied.
RESULTS: Nociceptin fits well into the binding pocket, the N-terminal FGGF
tetrapeptide is located in the inner region of the binding cavity, the noc
iceptin (5 - 7) interacts with the conservatively variable residues near th
e other end of binding pocket, and maybe determines selectivity of ORL1 rec
eptor over dynorphin A, the positively charged core of nociceptin (8-13) bi
nds predominantly with negatively charged EL-2 loop, which is thought to be
able to mediate receptor activation. The shortest fully active analogue of
nociceptin (1-13) is also discussed. The main difference between these two
opioids and nociceptin exists in the kinds and the number of conserved and
variable residues in the binding pocket and thereafter in the strength of
their interaction. Prediction for binding affinities of four stereoisomers
of lofentanyl has been performed based on their binding energies, the simil
ar pharmacophore of lofentanyl and other fentanyl analogs, and the good cor
relation between binding energies and their experimental binding affinities
(- logK(i) values). CONCLUSION: Ligand docking results from this study are
helpful in clarifying experimental observations of ligands interaction wit
h opioid receptors, thus furthering biological investigations.